It is essential for genomic tests to undergo rigorous assessment to ensure the standardization and quality assurance of the tests before providing genetic results back to individuals.

Watch our on-demand webinar with EMQN to find out how their EQA schemes support the standardization of genomic testing by assessing the quality and consistency of tests utilizing Revvity’s Mimix™ cell line-derived reference standards.

Rebecca Goodall qualified as a Clinical scientist in 2015 and has worked at EMQN as a Scientific Programme manager for five years. She is responsible for the management of the pharmacogenetics external quality assessment schemes (EQAs) and supports the management of other technical EQAs. Rebecca enjoys sharing EQA findings with the international genetics community and believes EQA offers a unique insight into clinical patient care on a global scale.

Before joining EMQN, Rebecca worked in a variety of clinical laboratory settings including immunology, histocompatibility and immunogenetics. She has a background in clinical laboratory quality management and HLA sequencing.

For research use only. Not for use in diagnostic procedures.